Persistence pays off with approval of distal myopathy drug

A drug to treat distal myopathy — a rare disorder characterized by progressive weakness of the distal muscles of the hands and feet, with patients losing the ability to walk in roughly 10 years — was recently approved for the first time worldwide, for use in Japan, following clinical trials at Tohoku University in Sendai.